Latest | F'cast | |
---|---|---|
Div Yield | 3.7% | 0.0% |
Div Cover | 1.3 | 1.4 |
Op Mrgn | 14.0% | 17.7% |
ROCE | 12.1% |
Latest | F'cast | |
---|---|---|
P/E | 20.8 | 19.6 |
PEG | n/a | 1.4 |
Pr/Revenue | 2.6 | 2.5 |
Pr/Book | 1.8 |
Latest | F'cast | |
---|---|---|
Revenue | -3.9% | 4.7% |
PBT | -12.1% | 44.9% |
EPS | -14.9% | 6.7% |
DPS | 0.9% | 1.4% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1,390.30 | 269.50 | 175.50p | 37.6 | n/a | -5% | 91.00p | 1.4% |
31-Dec-21 | 1,889.60 | 411.50 | 250.00p | 40.5 | 1.0 | +42% | 100.00p | 1.0% |
31-Dec-22 | 2,089.30 | 780.00 | 272.00p | 24.3 | 2.7 | +9% | 108.00p | 1.6% |
31-Dec-23 | 1,694.50 | 236.30 | 167.60p | 30.1 | n/a | -38% | 109.00p | 2.2% |
31-Dec-24 | 1,628.10 | 207.80 | 142.60p | 23.7 | n/a | -15% | 110.00p | 3.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,704.74 | 301.03 | 152.14p | 19.5 | 2.9 | +7% | 111.50p | 0.0% |
31-Dec-26 | 1,802.31 | 347.61 | 176.96p | 16.7 | 1.0 | +16% | 112.76p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Director Declaration | 27-Mar-2025 | 09:57 | RNS |
Director/PDMR Shareholding | 25-Mar-2025 | 12:30 | RNS |
Director/PDMR Shareholding | 25-Mar-2025 | 12:27 | RNS |
Chemical firm Croda warns sterling rise will den... | 25-Jun-2014 | Express & Star |
Croda warns strong pound to hit profits | 25-Jun-2014 | Telegraph |
Second Croda deal for Aquapharm | 13-Jul-2011 | The Scotsman |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
24-Mar-25 | Sell | Tom Brophy | 2,908.56p | 844 | £24,548.22 |
24-Mar-25 | Transfer From | Tom Brophy | 0.000p | 1,788 | £0.00 |
24-Mar-25 | Sell | Steve Foots | 2,908.56p | 3,249 | £94,499.03 |
Currency | UK Pounds |
Share Price | 2,960.00p |
Change Today | 68.00p |
% Change | 2.35 % |
52 Week High | 4,973.00 |
52 Week Low | 2,880.00 |
Volume | 398,203 |
Shares Issued | 142.54m |
Market Cap | £4,219.09m |
Beta | 0.01 |
RiskGrade | 108 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 1 |
Neutral | 9 |
Sell | 0 |
Strong Sell | 1 |
Total | 16 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 10-Apr-25 | 05-Sep-24 |
Paid | 28-May-25 | 08-Oct-24 |
Amount | 63.00p | 47.00p |
Time | Volume / Share Price |
15:17 | 3 @ 2,960.00p |
16:37 | 639 @ 2,960.00p |
16:35 | 3,766 @ 2,960.00p |
16:35 | 316 @ 2,960.00p |
16:35 | 106 @ 2,960.00p |
You are here: research